Min Wu

4.4k total citations
84 papers, 2.2k citations indexed

About

Min Wu is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Complementary and alternative medicine. According to data from OpenAlex, Min Wu has authored 84 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Molecular Biology, 12 papers in Cardiology and Cardiovascular Medicine and 12 papers in Complementary and alternative medicine. Recurrent topics in Min Wu's work include Gut microbiota and health (13 papers), Traditional Chinese Medicine Analysis (7 papers) and Lipoproteins and Cardiovascular Health (5 papers). Min Wu is often cited by papers focused on Gut microbiota and health (13 papers), Traditional Chinese Medicine Analysis (7 papers) and Lipoproteins and Cardiovascular Health (5 papers). Min Wu collaborates with scholars based in China, United States and Belgium. Min Wu's co-authors include Longtao Liu, Shengjie Yang, Ran Zhao, Yanwei Xing, Xiaoya Li, Xinye Li, Dan Li, Songzi Wang, Xiao Jin and Yu Cao and has published in prestigious journals such as Environmental Science & Technology, Journal of the American College of Cardiology and PLoS ONE.

In The Last Decade

Min Wu

81 papers receiving 2.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Min Wu China 27 1.1k 335 220 212 207 84 2.2k
Thamaraiselvan Rengarajan India 16 835 0.8× 240 0.7× 236 1.1× 142 0.7× 223 1.1× 32 2.8k
Samuel Santos Valença Brazil 34 871 0.8× 427 1.3× 202 0.9× 209 1.0× 286 1.4× 124 3.4k
Ya‐Long Feng China 23 1.5k 1.4× 225 0.7× 229 1.0× 259 1.2× 227 1.1× 33 3.0k
Michael Rothe Germany 31 727 0.7× 328 1.0× 186 0.8× 292 1.4× 178 0.9× 122 3.1k
Hongyan Li China 25 948 0.9× 232 0.7× 272 1.2× 204 1.0× 218 1.1× 89 2.4k
Theresa L. Pedersen United States 30 639 0.6× 364 1.1× 133 0.6× 187 0.9× 240 1.2× 66 2.5k
Manish Mishra United States 36 1.5k 1.4× 320 1.0× 287 1.3× 274 1.3× 181 0.9× 93 3.3k
Limin Lü China 30 1.3k 1.2× 195 0.6× 320 1.5× 162 0.8× 186 0.9× 96 2.6k
Victoria Ramírez Mexico 21 696 0.6× 185 0.6× 175 0.8× 158 0.7× 325 1.6× 48 2.5k
Fernando Toledo Chile 31 805 0.7× 200 0.6× 250 1.1× 129 0.6× 194 0.9× 88 2.9k

Countries citing papers authored by Min Wu

Since Specialization
Citations

This map shows the geographic impact of Min Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Min Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Min Wu more than expected).

Fields of papers citing papers by Min Wu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Min Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Min Wu. The network helps show where Min Wu may publish in the future.

Co-authorship network of co-authors of Min Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Min Wu. A scholar is included among the top collaborators of Min Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Min Wu. Min Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Yang, Yang, Yun Gu, Min Wu, et al.. (2025). Radiosensitizing effects of olaparib nanoparticles modified by Bifidobacterium antibodies on lung cancer. Reactive and Functional Polymers. 217. 106464–106464. 1 indexed citations
3.
Zhu, Guanghui, et al.. (2024). Co-morbid intersections of cancer and cardiovascular disease and targets for natural drug action: Reprogramming of lipid metabolism. Biomedicine & Pharmacotherapy. 176. 116875–116875. 6 indexed citations
4.
Yang, Shengjie, Yujuan Li, Zhou Li-jun, et al.. (2024). Copper homeostasis and cuproptosis in atherosclerosis: metabolism, mechanisms and potential therapeutic strategies. Cell Death Discovery. 10(1). 25–25. 44 indexed citations
5.
Wang, Taiping, Min Wu, Wuying Lang, et al.. (2023). Maternal effects drive intestinal development beginning in the embryonic period on the basis of maternal immune and microbial transfer in chickens. Microbiome. 11(1). 41–41. 18 indexed citations
6.
Li, Xiaoya, Jingyi Zhang, Zongliang Yu, et al.. (2023). Protective effects of paeoniflorin on cardiovascular diseases: A pharmacological and mechanistic overview. Frontiers in Pharmacology. 14. 1122969–1122969. 20 indexed citations
8.
Ren, Lili, et al.. (2023). Mannan oligosaccharides improve the fur quality of raccoon dogs by regulating the gut microbiota. Frontiers in Microbiology. 14. 1324277–1324277. 2 indexed citations
10.
Tan, Ying, et al.. (2023). MicroRNA in the Diagnosis and Treatment of Doxorubicin-Induced Cardiotoxicity. Biomolecules. 13(3). 568–568. 20 indexed citations
11.
Jin, Xiao, Shengjie Yang, Jing Lu, & Min Wu. (2022). Small, Dense Low-Density Lipoprotein-Cholesterol and Atherosclerosis: Relationship and Therapeutic Strategies. Frontiers in Cardiovascular Medicine. 8. 804214–804214. 48 indexed citations
13.
Wu, Min, Shengjie Yang, Guijian Liu, et al.. (2021). Treating unstable angina with detoxifying and blood-activating formulae: A randomized controlled trial. Journal of Ethnopharmacology. 281. 114530–114530. 7 indexed citations
14.
Li, Dan, Longtao Liu, Shengjie Yang, et al.. (2021). Exploring the Therapeutic Mechanisms of Huzhang–Shanzha Herb Pair against Coronary Heart Disease by Network Pharmacology and Molecular Docking. Evidence-based Complementary and Alternative Medicine. 2021. 1–14. 14 indexed citations
15.
Zhao, Ran, Shengjie Yang, Dan Li, et al.. (2021). Effects of Baduanjin Exercise on Antihypertensive Medication Reduction in Older Patients with Hypertension: A Study Protocol for a Randomized Controlled Trial. Evidence-based Complementary and Alternative Medicine. 2021. 1–9. 5 indexed citations
16.
Wang, Zhihan, Kai Guo, Yingying Liu, Canhua Huang, & Min Wu. (2021). Dynamic impact of virome on colitis and colorectal cancer: Immunity, inflammation, prevention and treatment. Seminars in Cancer Biology. 86(Pt 2). 943–954. 23 indexed citations
17.
Wang, Zuowei, et al.. (2017). A controlled, multi-center, randomized study of efficacy and safety of troxerutin and cerebroprotein hydrolysate injection for traumatic brain injury. Zhonghua shenjing waike zazhi. 33(7). 669–672. 1 indexed citations
19.
Wu, Min, et al.. (2012). Residue analysis and degradation dynamics of fenoxanil in rice. Acta Agriculturae Zhejiangensis. 24(5). 860–864. 2 indexed citations
20.
Luo, Man‐Li, Xiaoming Shen, Yu Zhang, et al.. (2006). Amplification and Overexpression of CTTN ( EMS1 ) Contribute to the Metastasis of Esophageal Squamous Cell Carcinoma by Promoting Cell Migration and Anoikis Resistance. Cancer Research. 66(24). 11690–11699. 122 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026